paramax has been researched along with metoclopramide in 5 studies
| Studies (paramax) | Trials (paramax) | Recent Studies (post-2010) (paramax) | Studies (metoclopramide) | Trials (metoclopramide) | Recent Studies (post-2010) (metoclopramide) |
|---|---|---|---|---|---|
| 5 | 2 | 0 | 5,044 | 1,216 | 623 |
| Protein | Taxonomy | paramax (IC50) | metoclopramide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.383 | |
| Myeloperoxidase | Homo sapiens (human) | 0.35 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.721 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.127 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 7.8 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.675 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.383 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 7.8 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 7.8 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.2 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.88 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.63 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.6237 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dexter, SL; Graham, AN; Johnston, ES; Ratcliffe, DM; Rose, AJ; Wilkinson, MI | 1 |
| Boston, PF | 1 |
| Cunningham, B; Dougall, JR; Nimmo, WS | 1 |
| Behan, P | 1 |
| Empson, M; Fitzharris, P; Sood, JD; Stewart, J | 1 |
2 trial(s) available for paramax and metoclopramide
| Article | Year |
|---|---|
Double-blind controlled study of paramax in the acute treatment of common and classical migraine.
Topics: Acetaminophen; Adult; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders | 1985 |
Paracetamol absorption from Paramax, Panadol and Solpadeine.
Topics: Acetaminophen; Administration, Oral; Adult; Caffeine; Codeine; Drug Combinations; Humans; Male; Metoclopramide | 1983 |
3 other study(ies) available for paramax and metoclopramide
| Article | Year |
|---|---|
Paracetamol absorption from Paramax, Panadol and Solpadeine.
Topics: Absorption; Acetaminophen; Caffeine; Codeine; Drug Combinations; Humans; Metoclopramide | 1983 |
Migraine: a rational approach to therapy.
Topics: Acetaminophen; Adolescent; Adult; Aged; Child; Drug Combinations; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders | 1982 |
Too much of a good thing, is it bad? Adrenaline on trial.
Topics: Acetaminophen; Adult; Angioedema; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Combinations; Drug Hypersensitivity; Epinephrine; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Medication Errors; Metoclopramide; Pulmonary Edema; Tongue Diseases; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |